共 48 条
Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury
被引:18
作者:
Hayashi, K
Banno, H
Kadomatsu, K
Takei, Y
Komori, K
Muramatsu, T
机构:
[1] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Vasc Surg, Nagoya, Aichi, Japan
来源:
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
|
2005年
/
288卷
/
05期
关键词:
molecular target;
phosphorothioate;
vascular restenosis;
D O I:
10.1152/ajpheart.00555.2004
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Restenosis is the major clinical problem of angioplasty. We have previously shown that neointima formation is strikingly suppressed in midkine (MK)- deficient mice. Neointima formation is restored if MK protein is administrated to the deficient mice. MK is a heparin- binding growth factor and implicated in the migration of inflammatory cells and vascular smooth muscle cells. Consistently, the suppression of neointima formation in the deficient mice is accompanied by suppression of recruitment of inflammatory cells into the vascular wall. Here, we evaluated the potential of MK antisense oligodeoxyribonucleotide (ODN) for the prevention of restenosis. We cloned the cDNA of rabbit MK, which showed a strongly conserved sequence in mammals. The balloon injury induced MK expression, with the maximum level occurring 7 - 14 days after angioplasty, in the rabbit carotid artery. Two antisense ODNs suppressed the production of MK in a rabbit kidney cell line, RK13 cells, one of which was then transfected into the arterial wall by means of lipofection immediately after balloon treatment. The antisense ODN suppressed MK induction in vivo and consequently suppressed neointima formation to 60% of the control level. These results suggest that MK is a candidate molecular target for the therapy for vascular restenosis.
引用
收藏
页码:H2203 / H2209
页数:7
相关论文